Map Key
Generic Enzyme
Generic kinase
Protein kinase
Lipid kinase
Generic phosphatase
Protein phosphatase
Lipid phosphatase
Generic phospholipase
Generic protease
RAS - superfamily
G beta/gamma
Regulators (GDI, GAP, GEF)
Generic channel
Ligand-gated channel
Voltage-gated channel
Normal process
Pathological process
Positive effect
Negative effect
Unspecified effect
Technical link
Disrupts in disease
Emerges in disease
Enhances in disease
Weakens in disease
Organsim specific interaction

Generic binding protein
Receptor ligand
Cell membrane glycoprotein
Transcription factor
Inorganic ion
Predicted metabolite or user's structure
Generic receptor
Receptors with enzyme activity

Normal process
Pathological process
Covalent modifications
Transcription regulation
MicroRNA binding
Influence on expression
Unspecified interactions
Pharmacological effect
Toxic effect
Group relation
Complex subunit
Similarity reaction
A complex or a group
Organism specific object

Development EGFR signaling pathway

Log In to Post A Comment

Development EGFR signaling pathway

EGFR signaling pathway

Epidermal growth factor receptor ( EGFR ) belongs to the ERBB family ofreceptor tyrosine kinases that contains four closely related members EGFR andERBB2-4. They couple the binding of the extracellular growth factor ligands tointracellular signaling pathways that regulate diverse biologic responses, includingproliferation, differentiation, cell motility, and survival [1].

Six ligands of EGFR are known. These are Epidermal growth factor ( EGF), Amphiregulin, Transforming growth factor alpha ( TGF-alpha ),Betacellulin, Heparin binding EGF-like growth factor ( HB-EGF ), andEpiregulin [2].

ErbB2 is a unique member of the ERBB family in that it does not bind any of theknown ligands with high affinity. However, it is the preferred heterodimeric partner forother EGFRs [1].

The ligand-induced receptor dimerization and subsequent autophosphorylation ofdistinct tyrosine residues creates docking sites for various membrane-targeted proteins.The cytoplasmic mediators that bind to EGFR phosphotyrosine residues are eitherthe adaptor proteins, such as SHC transforming protein 1 ( Shc ) , Growthfactor receptor-bound protein 2 ( GRB2 ) , Cas-Br-M ecotropic retroviraltransforming sequence ( c-Cbl ) , Docking protein 2 ( DOK2 ) and NCKadaptor protein 1 ( NCK1 ), or enzymes, such as Phospholipase C gamma 1 (PLC-gamma 1 ), v-Src sarcoma viral oncogene homolog ( c-Src ) and PTK2protein tyrosine kinase 2 ( FAK1 ).

The adaptors Shc and GRB2 recruit the exchange factor Son of sevenlesshomolog 1 ( SOS ) and form the complex consisting of Shc, GRB2 andSOS. Activated SOS activates small GTPase v-Ha-ras Harvey rat sarcomaviral oncogene homolog ( H-RAS ) by its conversion from the inactive GDP-boundingstate to the active GTP-bounding state. The activated H-RAS stimulates v-Raf-1murine leukemia viral oncogene homolog 1 ( c-Raf-1)/ Mitogen-activated proteinkinase kinase 1 and 2 ( MEK1 and MEK2 )/ Mitogen-activated protein kinase 1 and 3( ERK1/2 ) kinase cascade that leads to activation of the transcription factorsELK1 member of ETS oncogene family ( Elk-1 ), v-Myc myelocytomatosis viraloncogene homolog ( c-Myc ), and v-Fos FBJ murine osteosarcoma viral oncogenehomolog ( c-Fos ) [3].

The adaptor DOK2 associates with the GTPase-activating protein RAS p21 proteinactivator 1 ( p120GAP ) that reinforces intrinsic GTPase activity of H-RAS,thereby inactivating H-RAS. As a result, DOK2 can attenuate activation ofthe EGF-stimulated mitogen-activated protein kinase (MAPK) cascade [4].

The adaptor NCK1 couples EGFR stimulation to the activation of anotherMAPK-cascade, the JNK kinase cascade. NCK1 recruits p21-Activated kinase 1 (PAK1 ). NCK1/ PAK1 complex binds Mitogen-activated protein kinasekinase kinase 10 ( MLK2 ) and activates the JNK cascade consisting of MLK2/ Mitogen-activated protein kinase kinase 4 and 7 ( MEK4 and MKK7 )/ Mitogen-activated protein kinase 8 and 9 ( JNK1 and JNK2 ). Therecruitment of the cascade to the activated membrane receptor localizes MLK2 onthe plasma membrane where it is activated by its known upstream effectors, such asRas-related C3 botulinum toxin substrate 1 ( Rac1 ). Stimulation of JNK cascaderesults in activation of the transcription factors Elk-1, Jun oncogene (c-Jun ) and some others [5]. Dual specificity phosphatases 1 and 4 (MKP-1 and MKP-2 ) attenuate activation of the JNK cascade [6].

The adaptor GRB2 also binds via its SH3 domain with proline-rich regions of thec-Cbl protein. c-Cbl is tyrosine-phosphorylated by tyrosine kinase uponstimulation via the EGF receptor. EGF stimulation induces the association of c-Cblwith the regulatory p85 subunit of the Phosphatidylinositol 3-kinase ( PI3K reg classIA (p85) ) [7].

Activated PI3K cat class IA converts Phosphatidylinositol 4,5-biphosphate(PtdIns(4,5)P2) to Phosphatidylinositol 3,4,5-triphosphate ( PtdIns(3,4,5)P3 ).The latter is a second messenger involved in regulation of various processes [8]. PtdIns(3,4,5)P3 associates with the inner surface of the plasmamembrane and promotes the recruitment of proteins with pleckstrin homology (PH) domains.One of such proteins is serine/threonine kinase v-AKT murine thymoma viral oncogenehomolog ( AKT ). It is the essential mediator of various cell processes, such asapoptosis, cell cycle, protein synthesis, regulation of metabolism [9].

Enzymes such as PLC-gamma 1 or the cytoplasmic tyrosine kinase c-Srctie EGFR activation to the generation of secondary messengers and calciummetabolism or to mitogenic signaling cascades, respectively. EGFR recruits andphosphorylates PLC-gamma 1 [10].

Phosphorylated PLC-gamma 1 generates Diacylglycerol ( DAG ) andInositol-1,4,5-trisphosphate ( IP3 ) from PtdIns(4,5)P2 [11].

DAG activates many isoforms of protein kinase C (PKC), including conventionalisoforms alpha, beta, and gamma ( PKC-alpha, PKC-beta, and PKC-gamma ), as well asPKC-epsilon and PKC-theta. PKC-alpha, PKC-beta, PKC-gamma, andPKC-epsilon phosphorylate and activate c- Raf-1, thereby amplifying H-RAS/MEK1 and MEK2/ ERK1/2 kinase cascade [12], [13]. PKC-thetaactivates Nuclear factor NF-kappa-B inhibitor kinase beta (IKK-beta) resulting inactivation of the Nuclear factor NF-kappa-B ( NF-kB ) [14].

The cytoplasmic tyrosine kinase c-Src is involved in important cellularprocesses such as mitogenic signaling or cytoskeletal organization. Substrates of theEGF-stimulated c-Src include the EGFR itself, transcription factors of theSignal transducer and activator of transcription family, such as STAT3,Shc, cytoskeletal components and some other proteins [15].